Abstract
Intracerebral haemorrhage (ICH) is a devastating cerebrovascular disease, which accounts to 15% of all strokes. Among modifiable risk factors for ICH, hypertension is the most frequent. High blood pressure (BP) is detected in more than 75–80% of patients with ICH. Extremely elevated BP has been associated with early hematoma growth, a relatively frequent occurrence and powerful predictor of poor outcome in patients with spontaneous ICH. On the other hand, excessively low BP might cause cerebral hypoperfusion and ultimately lead to poor outcome. This review will analyse the most important trials that have tried to establish how far should BP be lowered during acute ICH. These trials have demonstrated either a small non-significant benefit (INTERACT-2, INTEnsive blood pressure Reduction in Acute Cerebral haemorrhage Trial) or no benefit (ATACH-2, Antihypertensive treatment of acute cerebral haemorrhage II study) when intensive systolic BP reduction was compared with modest or standard BP reduction. The more recent meta-analyses including studies investigating this issue yielded similar conclusions: aggressive BP control in the acute phase of ICH is not beneficial. For these reasons the 2018 European Society of Cardiology/ European Society of Hypertension Guidelines for the management of arterial hypertension, do not recommend treatment to immediately lower BP in patients with acute ICH and systolic BP < 220 mmHg. Careful lowering of SBP to less than 180 mmHg via i.v. Infusion may be considered only in patients with SBP ≥ 220 mmHg.
Similar content being viewed by others
References
Galassi FM, Habicht ME, Rühli FJ, De Carolis S. A unique case of stroke and upper limb paralysis in a mid-18th century natural mummy. Circ Res. 2017;121:338–40. https://doi.org/10.1161/circresaha.117.311427.
Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38:208–11. Available from: http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1649503.
Gale CP, Casadei B. Death from stroke in Europe: if you can’t measure it, you can’t improve it. Eur Heart J. 2018. https://doi.org/10.1093/eurheartj/ehy543 (EPub ahead of print).
Pistoia F, Sacco S, Degan D, Tiseo C, Ornello R, Carolei A. Hypertension and stroke: epidemiological aspects and clinical evaluation. High Blood Press Cardiovasc Prev. 2016;23:18–23. https://doi.org/10.1007/s40292-015-0115-2.
Shah R, Wilkins E, Nichols M, Kelly P, El-Sadi F, Wright FL, Townsend N. Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data. Eur Heart J. 2018. https://doi.org/10.1093/eurheartj/ehy378 (Epub ahead of print).
Kim BJ, Bae HJ, Wong L. Pathophysiology and mechanisms whereby hypertension may cause stroke. In: Aiyagari V, Gorelick P, editors. Hypertension and stroke, clinical hypertension and vascular diseases. Cham: Springer International Publishing AG Switzerland; 2016. p. 109–28.
Carnevale D, Lembo G. Hypertension and cerebrovascular dysfunction acute and chronic brain pathological alterations. High Blood Press Cardiovasc Prev. 2010;17:191–200. https://doi.org/10.2165/11311950-000000000-00000.
O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S, INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388:761–75. https://doi.org/10.1016/s0140-6736(16)30506-2.
Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1 25 million people. Lancet. 2014;383:1899–911. https://doi.org/10.1016/s0140-6736(14)60685-1.
Salvetti M, Paini A, Bertacchini F, Aggiusti C, Stassaldi D, Verzeri L, Saccà G, Muiesan ML. Therapeutic approach to hypertensive emergencies: hemorrhagic stroke. High Blood Press Cardiovasc Prev. 2018;25:191–5. https://doi.org/10.1007/s40292-018-0262-3.
Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J, INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9. https://doi.org/10.1016/s1474-4422(08)70069-3.
Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, Lindley R, Robinson T, Lavados P, Neal B, Hata J, Arima H, Parsons M, Li Y, Wang J, Heritier S, Li Q, Woodward M, Simes RJ, Davis SM, Chalmers J, INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–65. https://doi.org/10.1056/nejmoa1214609.
Butcher KS, Jeerakathil T, Hill M, Demchuk AM, Dowlatshahi D, Coutts SB, Gould B, McCourt R, Asdaghi N, Findlay JM, Emery D, Shuaib A, ICH ADAPT Investigators. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44:620–6. https://doi.org/10.1161/strokeaha.111.000188.
Tsivgoulis G, Katsanos AH, Butcher KS, Boviatsis E, Triantafyllou N, Rizos I, Alexandrov AV. Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology. 2014;83:1523–9. https://doi.org/10.1212/WNL.0000000000001696.
Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW, ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033–43. https://doi.org/10.1056/nejmoa1603460.
Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. How should we lower blood pressure after cerebral hemorrhage? A systematic review and meta-analysis. Cerebrovasc Dis. 2017;43:207–13. https://doi.org/10.1159/000462986.
Shi L, Xu S, Zheng J, Xu J, Zhang J. Blood pressure management for acute intracerebral hemorrhage: a meta-analysis. Sci Rep. 2018;7:14345. https://doi.org/10.1038/s41598-017-13111-x.
Gong S, Lin C, Zhang D, Kong X, Chen J, Wang C, Li Z, Chen R, Sheng P, Dong Y, Hou L. Effects of intensive blood pressure reduction on acute intracerebral hemorrhage: a systematic review and meta-analysis. Sci Rep. 2017;7:10694. https://doi.org/10.1038/s41598-017-10892-z.
Boulouis G, Morotti A, Goldstein JN, Charidimou A. Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiatry. 2017;88:339–45. https://doi.org/10.1136/jnnp-2016-315346.
Carandini T, Bozzano V, Scarpini E, Montano N, Solbiati M. Intensive versus standard lowering of blood pressure in the acute phase of intracranial haemorrhage: a systematic review and meta-analysis. Intern Emerg Med. 2018;13:95–105. https://doi.org/10.1007/s11739-017-1716-7.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Authors/Task Force Members. ESC/ESH Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041. https://doi.org/10.1097/hjh.0000000000001940.
van den Born BH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, Mahfoud F, Amraoui F, Persu A, Kahan T, Agabiti Rosei E, de Simone G, Gosse P, Williams B. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother [Internet]. 2018; Available from: https://academic.oup.com/ehjcvp/advance-article/doi/10.1093/ehjcvp/pvy032/5079054.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Mulè, G., Sorce, A., Giambrone, M. et al. The Unsolved Conundrum of Optimal Blood Pressure Target During Acute Haemorrhagic Stroke: A Comprehensive Analysis. High Blood Press Cardiovasc Prev 26, 119–126 (2019). https://doi.org/10.1007/s40292-019-00305-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40292-019-00305-9